サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1785397

コンシューマーヘルスケア市場 - 世界の産業規模、シェア、動向、機会、予測：製品別、流通チャネル別、地域別、競合、2020年～2030年

Consumer Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

コンシューマーヘルスケア市場 - 世界の産業規模、シェア、動向、機会、予測：製品別、流通チャネル別、地域別、競合、2020年～2030年
出版日: 2025年08月06日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

コンシューマーヘルスケアの世界市場は、2024年には4,056億4,000万米ドルに達し、2030年までのCAGRで8.14%、予測期間中に目覚ましい成長を遂げると予測されています。

コンシューマーヘルスケア市場には、ウェルネス、口腔衛生、栄養、皮膚の健康に関連する幅広い製品が含まれます。これらの製品は主に、ヘルスケア専門家の処方箋なしに消費者が直接購入できる一般用医薬品（OTC）で構成されています。コンシューマーヘルスケア市場の成長を促す要因はいくつかあります。患者中心の治療に対する需要が高まっており、個人が自分の健康と幸福をよりコントロールするようになっています。医療インフラの改善により、コンシューマーヘルスケア製品がより多くの人々にとって利用しやすくなっています。

市場概要
予測期間 2026-2030
市場規模：2024年 4,056億4,000万米ドル
市場規模：2030年 6,435億7,000万米ドル
CAGR：2025年～2030年 8.14%
急成長セグメント 栄養補助食品
最大市場 北米

コンシューマーヘルスケア市場の主な促進要因のひとつは、セルフメディケーションの傾向の高まりです。ヘルスケア費用の増加に伴い、人々は処方薬に代わる費用対効果の高い選択肢としてOTC製品を利用するようになっています。病気にかかりやすい老年人口の増加も、コンシューマーヘルスケア製品の需要を高めています。メンタルヘルスの悪化も市場を牽引する要因のひとつであり、精神的な健康のためにOTCソリューションを求める人が増えています。ウェルネスと予防医学の承認と可処分所得の増加が、コンシューマーヘルスケア市場の成長をさらに後押ししています。

老人人口の増加は、コンシューマーヘルスケア市場の拡大に重要な役割を果たすと予想されます。世界保健機関（WHO）によると、2050年までに世界の60歳以上の人口は21億人に達します。このような高齢化社会では、消化器疾患や筋肉痛など加齢に伴う病気にかかりやすくなり、OTC医薬品や栄養補助食品の需要が高まる。

主な市場促進要因

健康意識の高まり

主な市場課題

規制遵守の急増

主な市場動向

天然およびハーブ製品の需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のコンシューマーヘルスケア市場に与える影響

第5章 顧客の声

第6章 世界のコンシューマーヘルスケア市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別（OTC医薬品、栄養補助食品、その他）
    • 流通チャネル別（小売、オンライン、病院）
    • 地域別
  • 企業別（2024）
  • 市場マップ（製品別、流通チャネル別、地域別）

第7章 アジア太平洋地域のコンシューマーヘルスケア市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第8章 欧州のコンシューマーヘルスケア市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • 英国

第9章 北米のコンシューマーヘルスケア市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米のコンシューマーヘルスケア市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのコンシューマーヘルスケア市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第14章 世界のコンシューマーヘルスケア市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Johnson & Johnson（Kenvue Inc.）
  • Haleon Plc
  • Bayer AG
  • Procter & Gamble Company
  • Sanofi SA
  • BASF SE
  • Teva Pharmaceutical Industries
  • Abbott Laboratories
  • STADA Arzneimittel AG
  • Amway Corporation

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 4680

Global Consumer Healthcare Market was reached reach USD 405.64 billion by 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.14% through 2030. The consumer healthcare market encompasses a wide range of products related to wellness, oral health, nutrition, and skin health. These products primarily consist of over the counter (OTC) drugs that can be purchased directly by consumers without a prescription from a healthcare professional. There are several factors driving the growth of the consumer healthcare market. There is an increasing demand for patient-centric treatments, where individuals are taking more control of their own health and well-being. The improvements in healthcare infrastructure have made consumer healthcare products more accessible to a larger population.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 405.64 Billion
Market Size 2030USD 643.57 Billion
CAGR 2025-20308.14%
Fastest Growing SegmentDietary Supplements
Largest MarketNorth America

One of the key drivers of the consumer healthcare market is the rising trend of self-medication. With the growth in healthcare costs, people are turning to OTC products as a more cost-effective alternative to prescription medications. The increase in the geriatric population, who are more prone to contracting diseases, has also contributed to the demand for consumer healthcare products. Mental health deterioration is another factor driving the market, as more people are seeking OTC solutions for their mental well-being. The approval of wellness and preventive medicine, coupled with the rise in disposable income, has further boosted the growth of the consumer healthcare market.

The growth in the geriatric population is expected to play a significant role in the expansion of the consumer healthcare market. According to the World Health Organization (WHO), by 2050, the global population of individuals aged 60 years and older will reach 2.1 billion. This aging population is more susceptible to age-related diseases, such as digestive disorders and muscle pain, which in turn drives the demand for OTC pharmaceuticals and dietary supplements.

Key Market Drivers

Rise in Health Awareness

Health awareness plays a crucial and ever-evolving role in shaping the dynamic consumer healthcare market. In this age of technological advancements, individuals now have unprecedented access to a vast array of health-related information. From understanding the intricacies of disease symptoms to delving into comprehensive research on preventive measures and treatment options, the digital world has truly revolutionized the way we acquire knowledge about our well-being. For instance, in August 2024, Pfizer and Eli Lilly announced plans to sell their medications directly to consumers, bypassing traditional pharmacy channels. This strategic shift aims to improve access, reduce costs, and streamline the purchasing process for patients. By embracing a direct-to-consumer model, both companies seek to strengthen customer engagement, enhance brand loyalty, and respond to growing demand for more convenient and affordable healthcare solutions.

This newfound accessibility to health information has given rise to a generation of more informed consumers who are increasingly proactive when it comes to their own health. Gone are the days when individuals solely focused on treating illnesses; now, consumers are taking charge of their well-being by adopting preventive healthcare measures. This transformative trend is clearly evident in the growing demand for vitamins and dietary supplements, fitness equipment, and routine health check-ups.

Digital platforms have emerged as powerful catalysts in promoting health awareness on a global scale. From ubiquitous social media platforms to innovative health apps and informative online platforms, individuals now have an abundance of resources to aid them in their journey towards better health and wellness. These digital avenues empower individuals to make informed decisions and take responsibility for their own well-being. These platforms have created unprecedented opportunities for companies to connect with consumers, offering a diverse range of health products and driving the growth of the consumer healthcare market.

Another notable shift in consumer behavior is the growing preference for self-medication, which has led to a significant rise in the sales of over-the-counter (OTC) products. Consumers are increasingly seeking out dietary supplements to enhance their immune systems and maintain a balanced and healthy lifestyle.

As the world continues to evolve, health awareness will remain a pivotal force shaping the consumer healthcare market. With technology as an enabler, the possibilities for further advancement and innovation in promoting health and wellness are limitless.

Key Market Challenges

Surge in Regulatory Compliance

Regulatory compliance is a critical aspect of business operations, particularly in the consumer healthcare market. It encompasses the meticulous process of ensuring adherence to laws, regulations, guidelines, and specifications that govern various business processes. By complying with these regulations, organizations can guarantee the safety, efficacy, and quality of healthcare products and services.

However, the surge in regulatory compliance poses significant challenges for businesses operating in the consumer healthcare market. With strict regulations enforced by authorities such as the Food and Drug Administration (FDA) in the U.S. and the European Medicines Agency (EMA) in Europe, companies must navigate a complex landscape of evolving requirements. Staying up-to-date and ensuring compliance can be a daunting task, as failure to do so can result in hefty fines, legal consequences, damage to brand reputation, and loss of consumer trust.

Adding to the complexity is the global nature of the consumer healthcare market, where companies must adhere to diverse regulatory standards across different countries and regions. This diversity further amplifies the challenges faced by businesses, requiring them to allocate significant resources to navigate and comply with a multitude of regulations.

The surge in regulatory compliance has a profound impact on the consumer healthcare market. It drives up the cost of product development and extends the time-to-market, ultimately reducing overall profitability. The fear of non-compliance can hinder innovation, as companies may become risk-averse to avoid potential regulatory pitfalls.

Key Market Trends

Growing Demand of Natural and Herbal Products

Natural and herbal products have been utilized for centuries in traditional medicine systems across diverse cultures, owing to their perceived therapeutic properties. In recent years, these products have experienced a surge in popularity, making their way into mainstream consumer healthcare. This shift can be attributed to a growing awareness of their potential health benefits and an increasing preference for natural alternatives over synthetic counterparts.

Consumers are now actively seeking out natural and herbal alternatives for a wide range of health issues. From common ailments like colds and flu to chronic conditions such as heart disease and diabetes, individuals are exploring the potential benefits of these products. This trend expands beyond medications alone and encompasses natural supplements, skincare products, and even food and beverages with health-boosting properties.

Several factors contribute to the escalating demand for natural and herbal products in the consumer healthcare market. Firstly, a mounting body of scientific research supports the efficacy of specific natural and herbal remedies, validating their usage and instilling confidence in consumers. Secondly, individuals are becoming increasingly health-conscious and proactive in their pursuit of well-being. They are now more aware of the potential side effects associated with synthetic drugs and are actively seeking safer and more natural alternatives.

The advent of digital platforms has significantly facilitated consumer access to information about natural and herbal products. Through online channels, individuals can easily gather knowledge about these products and make informed purchase decisions. This accessibility has further fueled the growth of the natural and herbal product market.

This prevailing trend has not only spurred innovation in the market but has also prompted companies to invest in research and development to create novel natural and herbal products. The growing demand has attracted new players to enter the market, intensifying competition and driving further advancements.

Key Market Players

  • Johnson & Johnson (Kenvue Inc.)
  • Haleon Plc
  • Bayer AG
  • Procter & Gamble Company
  • Sanofi SA
  • BASF SE
  • Teva Pharmaceutical Industries
  • Abbott Laboratories
  • STADA Arzneimittel AG
  • Amway Corporation

Report Scope:

In this report, the Global Consumer Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Consumer Healthcare Market, By Product:

  • OTC Pharmaceuticals
  • Dietary Supplements
  • Others

Consumer Healthcare Market, By Distribution Channel:

  • Retail
  • Online
  • Hospitals

Consumer Healthcare Market, By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Consumer Healthcare Market.

Available Customizations:

Global Consumer Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Applications
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Consumer Healthcare Market

5. Voice of Customers

  • 5.1. Factors Affecting Purchase Decision
  • 5.2. Brand Awareness
  • 5.3. Sources of Information
  • 5.4. Product Preferences
  • 5.5. Trends and Innovation

6. Global Consumer Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (OTC Pharmaceuticals, Dietary Supplements, Others)
    • 6.2.2. By Distribution Channel (Retail, Online, Hospitals)
    • 6.2.3. By Region
  • 6.3. By Company (2024)
  • 6.4. Market Map (By Product, By Distribution Channel, By Region)

7. Asia Pacific Consumer Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Asia Pacific: Country Analysis
    • 7.3.1. China Consumer Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. India Consumer Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. Australia Consumer Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Japan Consumer Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. South Korea Consumer Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Distribution Channel

8. Europe Consumer Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Consumer Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. Germany Consumer Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Spain Consumer Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. Italy Consumer Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. United Kingdom Consumer Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Distribution Channel

9. North America Consumer Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Consumer Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Mexico Consumer Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Canada Consumer Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Distribution Channel

10. South America Consumer Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Consumer Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Argentina Consumer Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. Colombia Consumer Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Distribution Channel

11. Middle East and Africa Consumer Healthcare Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Distribution Channel
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Consumer Healthcare Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Distribution Channel
    • 11.3.2. Saudi Arabia Consumer Healthcare Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Distribution Channel
    • 11.3.3. UAE Consumer Healthcare Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Product Launches
  • 13.3. Mergers & Acquisitions

14. Global Consumer Healthcare Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Product

16. Competitive Landscape

  • 16.1. Johnson & Johnson (Kenvue Inc.)
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
  • 16.2. Haleon Plc
  • 16.3. Bayer AG
  • 16.4. Procter & Gamble Company
  • 16.5. Sanofi SA
  • 16.6. BASF SE
  • 16.7. Teva Pharmaceutical Industries
  • 16.8. Abbott Laboratories
  • 16.9. STADA Arzneimittel AG
  • 16.10. Amway Corporation

17. Strategic Recommendations

18. About Us & Disclaimer